+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Cardiovascular Drugs Market Research Reports

The United States Peripheral Artery Disease Interventions Landscape, Procedure and Technology Trends, Brand Perception, Competitive Intelligence and Future Outlook - Product Thumbnail Image

The United States Peripheral Artery Disease Interventions Landscape, Procedure and Technology Trends, Brand Perception, Competitive Intelligence and Future Outlook

  • Report
  • January 2023
  • 50 Pages
  • United States
From
ANCA-Associated Vasculitis Market Assessment: Epidemiology, Treatment Landscape, Unmet Needs, Emerging Therapies, and Value & Access - Product Thumbnail Image

ANCA-Associated Vasculitis Market Assessment: Epidemiology, Treatment Landscape, Unmet Needs, Emerging Therapies, and Value & Access

  • Report
  • January 2023
  • 25 Pages
  • Global
Global Pulmonary Arterial Hypertension (PAH) Equipment: Market Size & Forecasts 2022-2028 - Product Thumbnail Image

Global Pulmonary Arterial Hypertension (PAH) Equipment: Market Size & Forecasts 2022-2028

  • Report
  • January 2022
  • 230 Pages
  • Global
From
Finerenone - Product Thumbnail Image

Finerenone

  • Report
  • February 2019
  • 19 Pages
  • Global
From
Ischemic Stroke Market and Forecast Analysis 2024 - Product Thumbnail Image

Ischemic Stroke Market and Forecast Analysis 2024

  • Drug Pipelines
  • January 2019
  • 163 Pages
  • Global
From
Opsumit - Product Thumbnail Image

Opsumit

  • Report
  • October 2018
  • 19 Pages
  • Global
From
Activase - Product Thumbnail Image

Activase

  • Report
  • July 2018
  • 14 Pages
  • Global
From
Plavix - Product Thumbnail Image

Plavix

  • Report
  • July 2018
  • 27 Pages
  • Global
From
Lovaza - Product Thumbnail Image

Lovaza

  • Report
  • June 2018
  • 11 Pages
  • Global
From
Drug Analysis: Natrecor - Product Thumbnail Image

Drug Analysis: Natrecor

  • Drug Pipelines
  • February 2018
  • 12 Pages
  • Global
From
Drug Overview: Mircera - Product Thumbnail Image

Drug Overview: Mircera

  • Drug Pipelines
  • January 2018
  • 20 Pages
  • Global
From
Plavix - API Insight, 2024 - Product Thumbnail Image

Plavix - API Insight, 2024

  • Drug Pipelines
  • January 2024
  • 30 Pages
  • Global
From
Alpha 2C Adrenergic Receptor (Alpha 2 Adrenergic Receptor Subtype C4 or Alpha 2C Adrenoreceptor or ADRA2C) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Alpha 2C Adrenergic Receptor (Alpha 2 Adrenergic Receptor Subtype C4 or Alpha 2C Adrenoreceptor or ADRA2C) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • December 2022
  • 51 Pages
  • Global
From
Heart Transplant Rejection Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Heart Transplant Rejection Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • November 2022
  • 35 Pages
  • Global
From
Hereditary Angioedema (HAE) (C1 Esterase Inhibitor [C1-INH] Deficiency) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Hereditary Angioedema (HAE) (C1 Esterase Inhibitor [C1-INH] Deficiency) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • November 2022
  • 79 Pages
  • Global
From
Myocardial Fibrosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Myocardial Fibrosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • November 2022
  • 53 Pages
  • Global
From
Hypertension Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Hypertension Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • November 2022
  • 589 Pages
  • Global
From
Heterozygous familial hypercholesterolemia (heFH) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Heterozygous familial hypercholesterolemia (heFH) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • October 2022
  • 63 Pages
  • Global
From
Hypercholesterolemia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Hypercholesterolemia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • October 2022
  • 210 Pages
  • Global
From
Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor or Heparin Binding Growth Factor 2 or FGF2) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor or Heparin Binding Growth Factor 2 or FGF2) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • October 2022
  • 53 Pages
  • Global
From
Loading Indicator

The Cardiovascular Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat cardiovascular diseases. These drugs are used to treat conditions such as hypertension, coronary artery disease, congestive heart failure, and arrhythmias. Cardiovascular drugs are also used to reduce the risk of stroke, heart attack, and other cardiovascular events. The market is composed of a variety of companies, ranging from large multinationals to small start-ups. Major players in the market include Pfizer, Merck, Novartis, Sanofi, and Bristol-Myers Squibb. These companies are involved in the research, development, and production of cardiovascular drugs. Additionally, there are a number of smaller companies that specialize in the production of generic cardiovascular drugs. These companies include Teva Pharmaceuticals, Mylan, and Sun Pharmaceuticals. Show Less Read more